XML 70 R33.htm IDEA: XBRL DOCUMENT v3.20.1
Equity-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2020
Equity-Based Compensation  
Schedule of equity-based compensation expense

The Company’s equity-based compensation expense, by type of award, was as follows for the three months ended March 31, 2019 and 2020 (in thousands):

Three months ended March 31,

   

2019

   

2020

Restricted stock unit awards

$

3,972

1,878

Stock options

344

Performance share unit awards

2,959

922

Antero Midstream Partners phantom unit awards (1)

1,125

160

Equity awards issued to directors

503

369

Total expense

$

8,903

3,329

(1)Antero Resources recognized compensation expense for equity awards granted under both the Plan and the AMP Plan because the awards under the AMP Plan are accounted for as if they are distributed by Antero Midstream Partners to Antero Resources. Antero Resources allocates a portion of equity-based compensation expense related to grants prior to the Transactions to Antero Midstream Partners based on its proportionate share of Antero Resources’ labor costs. Through March 12, 2019, the total amount of equity-based compensation is included in the consolidated financial statements of Antero Resources; and effective March 13, 2019 (date of deconsolidation), the amount allocated to Antero Midstream Partners is no longer reflected in Antero Resources consolidated financial statements. See Note 3 to the unaudited condensed consolidated financial statements for further discussion on the Transactions.
Summary of restricted stock and restricted stock unit awards activity

Weighted

average

Aggregate

Number of

grant date

intrinsic value

  

shares

  

fair value

  

(in thousands)

Total awarded and unvested—December 31, 2019

2,370,575

$

12.81

$

6,756

Granted

4,644,934

$

2.39

Vested

(191,216)

$

5.04

Forfeited

(69,293)

$

13.07

Total awarded and unvested—March 31, 2020

6,755,000

$

5.86

$

4,816

Summary of stock option activity

Weighted

Weighted

average

average

remaining

Intrinsic

Stock

exercise

contractual

value

  

options

  

price

  

life

  

(in thousands)

Outstanding at December 31, 2019

467,633

$

50.64

5.05

$

Granted

$

Exercised

$

Forfeited

(8,339)

$

52.36

Expired

$

Outstanding at March 31, 2020

459,294

$

50.61

4.77

$

Vested or expected to vest as of March 31, 2020

459,294

$

50.61

4.77

$

Exercisable at March 31, 2020

459,294

$

50.61

4.77

$

Schedule of outstanding unvested restricted stock awards vesting schedule

Weighted

average

Aggregate

Number of

grant date

intrinsic value

   

units

   

fair value

   

(in thousands)

Total awarded and unvested—December 31, 2019

657,757

$

14.71

$

4,992

Granted

$

Vested

(10,120)

$

15.81

Forfeited

(9,496)

$

13.75

Total awarded and unvested—March 31, 2020

638,141

$

14.70

$

1,340